Burden of Glucocorticoid Use and Risk of Toxicities Among Patients with Immunoglobulin-G4-Related Disease: A Retrospective US-Based Claims Study
In this retrospective, claims-based analysis, high glucocorticoid use was seen in half of patients with IgG4-RD during the first year following diagnosis. Patients with high glucocorticoid use experienced significantly more incident glucocorticoid-related toxicities than those with low use during this first year.
Authors
- Zachary S. Wallace (ORCID: https://orcid.org/0000-0003-4708-7038)
- Elizabeth Serra (ORCID: https://orcid.org/0000-0002-2832-5355)
- Patrick Gagnon‐Sanschagrin (ORCID: https://orcid.org/0000-0002-3582-9447)
- Haridarshan Patel (ORCID: https://orcid.org/0000-0002-1827-5163)
- Kristina R. Patterson (ORCID: https://orcid.org/0000-0002-6421-6869)
- J. Park
- Vikesh K. Singh
- Annie Guérin
Institutions
- Amgen (United States) (US)
- Johns Hopkins University (US)
- Massachusetts General Hospital (US)
- ENT and Allergy (US)
- Group for Research in Decision Analysis (CA)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1007/s40744-025-00763-9
- Citations
- 4
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 6.67
Funders
- Amgen